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 Obstructive nephropathy is one of the 
common causes of acute renal failure and 
end-stage renal disease. Many animal 
 Current knowledge supports further 
exploration of the complex interplay 
between the microRNA machinery and 
endosomal vesicles, as well as the mecha-
nisms of cargo loading into microvesicles 
and exosomes, the recognition of target 
cells by MPs, and the alteration of gene 
and protein expression in target cells by 
cargo of MPs ( Figure 1 ). Better under-
standing of the biology of MPs and their 
content is important before genetically 
altered vesicles can be considered as 
potential novel therapeutic carriers. 
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 Intrarenal urothelial 
transformation after obstruction: 
a novel metaplasia 
 Weei-Yuarn  Huang 1 and  Seymour  Rosen 2 
 Obstructive nephropathy is a major cause of acute renal failure and 
end-stage renal disease. We discuss the new findings of Girshovich 
 et al. , who show that transformation of intrarenal urothelium into a 
bladder-like urothelium depends on the activation of the FGF7 – FGFR2 
signaling pathway following acute ureteral obstruction. A possible link 
between hypoxia-inducible factor 1  and the FGF – FGFR signaling 
pathway is suggested. 
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models have been developed to study the 
renal consequences of ureteral obstruc-
tion in the events of acute, chronic, or 
congenital ureteropelvic junction obstruc-
tion. 1 Most studies on renal parenchyma 
alterations have focused on glomerular 
changes, tubulointerstitial injury, and 
fi brosis. 2,3 Instead, Girshovich  et al. 4 (this 
issue) turn their attention to a small group 
of cells called the intrarenal urothelium 
that resides near the fornices (corticomed-
ullary junction). 
 Th e intrarenal urothelium is morpho-
logically and phenotypically distinct from 
the bladder urothelium. Th e renal urothe-
lium, near the fornices, is composed of 
one- or two-layered epithelium, whereas 
the bladder epithelium is a multilayered 
epithelium consisting of basal cells, inter-
mediate cells, and superfi cial umbrella 
cells. The apical surface of a bladder 
urothelium contains urothelial plaques 
that contribute to a tight permeability 
barrier, thus preventing rupture during 
bladder distension and the infl ux of urine 
from the bladder lumen. Th e urothelial 
plaques contain four major integral mem-
brane proteins, uroplakins Ia, Ib, II, and 
III. 5 Th e renal urothelium near the for-
nices, in contrast, showed much weaker 
uroplakin immunostaining compared 
with typical umbrella cells of the bladder 
urothelium. 6 Although the bladder 
urothelium is constantly subjected to pres-
sure changes, no signifi cant stretching 
occurs in the intrarenal urothelium under 
physiological conditions. In the event of 
hydronephrosis secondary to ureteral 
obstruction, the intrarenal urothelium 
becomes the first barrier subjected 
to pressure-induced stretching and 
deformation. 
 Using an adult mouse unilateral ureteral 
obstruction (UUO) model, Girshovich 
 et al. 4 designed a series of experiments to 
examine the morphological and pheno-
typical alterations of intrarenal urothe-
lium subjected to increased intrapelvic 
pressure. Th ey were able to demonstrate 
that the intrarenal urothelium diff erenti-
ated into a  ‘ bladder-like ’ urothelium fol-
lowing UUO. Th is bladder-like urothelium 
was characterized by a multilayered 
epithelium with strong expression of 
uroplakins Ib, II, and III. Th ese fi ndings 
were further substantiated by electron 
microscopy examination, in which the 
transformed renal urothelium within the 
obstructed kidney showed abundant 
uroplakin-containing vesicles and thick-
ened asymmetric unit membrane cover-
ing the entire apical surface, suggesting 
a much more efficient barrier to water 
and solutes compared with normal renal 
urothelium. 
 The authors also made several very 
interesting observations. Th ere was a sig-
nifi cant increase in the proliferation index 
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(as measured by Ki-67 labeling index) one 
day aft er ureteral obstruction. Th e prolif-
eration activity peaked on day 2 and 
declined on day 3. Notably, removal of the 
clamp on day 2 (and assessment of the 
proliferation index one day aft er) signifi -
cantly inhibited proliferation activity, sug-
gesting that proliferation of renal 
urothelium following UUO is dependent 
on stretching and pressure. Furthermore, 
the activated form of fi broblast growth 
factor receptor 2 (FGFR2), phospho-
FGFR2, was detected in renal urothelium 
following UUO, but not in control kidney. 
It appears that the increased phosphoryla-
tion of FGFR2 was due to dimer forma-
tion of FGFR2 protein. mRNA of FGF7, 
the ligand of FGFR2, was also signifi cantly 
increased following UUO. Finally, the 
injection of FGFR2 antisense probe 
completely inhibited the Ki-67 labeling 
index. Together, these fi ndings indicate 
that proliferation of renal urothelium 
following UUO is dependent on the 
activation of the FGF7 – FGFR2 signaling 
pathway. 
 Th e fi ndings of transformation of intra-
renal urothelium into a bladder-like 
urothelium following UUO, depending 
on the activation of the FGF7 – FGFR2 sig-
naling pathway, are novel and have never 
been studied in human or other animal 
models. However, as the literature sug-
gested, lesions or pathways induced 
by ureteral obstruction may be model 
dependent. It would be interesting to 
examine whether these novel fi ndings can 
be applied to neonatal / fetal animal mod-
els for congenital ureteropelvic junction 
obstruction, the most common cause of 
obstructive nephropathy in children. 
 Can the activation of the FGF7 – FGFR2 
signaling pathway in the renal urothelium 
following UUO extend to the other seg-
ments of renal tubules that are considered 
by many studies to be the primary site of 
injury following obstruction? Indeed, the 
authors also observed some phospho-
FGFR2-positive tubule cells following 
UUO, although the extent and location of 
positive tubule cells are not discussed in 
detail. In adult animals, UUO induces 
rapid elevation of intrapelvic pressure, 
which is immediately transmitted to the 
renal tubules. Th e intrapelvic pressure is 
increased transiently, as the combination 
of pelvic dilatation, reduction of renal 
blood fl ow, and glomerular fi ltration, as 
well as other hemodynamic factors, con-
tributes to the rapid decline and normali-
zation of intratubular pressure. It is 
interesting to note that the rapid rise and 
fall of the proliferation index of renal 
urothelium following UUO appears to be 
consistent with the transient nature of 
increased intrapelvic pressure. Studies 
using  in vitro models of mechanical 
stretch may provide further insights into 
the role of the FGF7 – FGFR2 signaling 
pathway in tubular lesions following 
UUO. 
 Ischemic insult to the renal tubules, sec-
ondary to a signifi cant reduction of renal 
blood fl ow 2 hours aft er UUO, has been 
implicated as an early inducer of renal 
lesions following obstruction. Interest-
ingly, the activation of the FGF7 – FGFR2 
pathway and proliferation of renal urothe-
lium following UUO are similar to the 
early events following ischemia – reper-
fusion injury in the kidney. Earlier study 
by the same group has demonstrated that 
renal urothelial cells near the fornix were 
the fi rst epithelium to proliferate together 
with phosphorylation of FGFR2 and 
upregulation of FGF7 following renal 
ischemia – reperfusion injury. 7 Perhaps the 
induction of this urothelial proliferation 
after ischemia reflow and the special 
nature of the lining epithelium in the 
fornix may be related to a critical zone in 
which hypoxia occurs with consequent 
upregulation of such factors as hypoxia-
inducible factor 1  (HIF-1  ). 8 Some stud-
ies in other organs have suggested a role 
of HIF-1  in regulating the FGF – FGFR 
pathway. 9,10 For example, in  Drosophila , 
the FGF-FGFR pathway controls the 
branching of the respiratory system dur-
ing organ development. It has been shown 
that FGF expression is regulated by 
hypoxia with subsequent induction of the 
 Drosophila homolog of HIF, sima, to 
ensure tracheal morphogenesis matching 
cellular oxygen need. 10 Th us, more ques-
tions need to be addressed in future stud-
ies: Can pressure and stretching alone 
(independent of hypoxia) activate the 
FGF7 – FGFR2 pathway following UUO? 
Is there a link between HIF-1  and the 
activation of the FGF7 – FGFR2 pathway? 
 In summary ( Figure 1 ), the study by 
Girshovich  et al. 4 suggests that the FGF7 –
 FGFR2 signaling pathway is a novel key 
player in the pathogenesis of renal paren-
chymal alterations in ureteral obstruction, 
which may warrant further studies to 
explore the possible interaction between 
this pathway and the other existing 
pathways that lead to renal fi brosis. Th e 
transformation from a single layer of 
urothelium into a bladder-like epithelium 
is probably an adaptive response to ensure 
an eff ective barrier during hydronephro-
sis. As happens with the other organs, 
adaptive response may become a double-
edged sword, initially protecting but later 
causing damage to renal tissue. 
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 Figure 1  |  Following UUO, renal urothelium is transformed into a multilayered epithelium, 
depending on the increased expression of FGF7 in fibroblasts and the activation of FGFR2 
(not shown) in epithelial cells. HIF-1  , hypoxia-inducible factor 1  . 
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 C3 glomerulopathy: what ’ s in 
a name ? 
 Vivette D.  D ’ Agati 1 and  Andrew S.  Bomback 2 
 Whereas early classifications of membranoproliferative glomerulo-
nephritis (MPGN) were based on morphologic features, the modern 
approach is directed at immunofluorescence findings. Glomerular 
deposits of C3 alone, without immunoglobulin, are the hallmark of 
alternative complement pathway dysregulation through inherited or 
acquired defects. These immunoglobulin-negative forms are referred 
to as C3 glomerulopathy, which encompasses both dense deposit 
disease and C3 glomerulonephritis. Distinguishing C3 glomerulopathy 
from immunoglobulin-mediated MPGN is opening the way to better 
diagnostic, prognostic, and treatment algorithms. 
 Kidney International (2012)  82, 379 – 381.  doi: 10.1038/ki.2012.80 
 Among glomerular diseases, none has 
undergone greater conceptual metamor-
phosis over the past fi ve years than mem-
branoproliferative glomerulonephritis 
(MPGN). In the 1970s, before there was 
knowledge of pathogenesis, MPGN was 
categorized on the basis of histologic and 
ultrastructural fi ndings. 1 – 3 Th e membran-
oproliferative pattern of glomerular injury 
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is defi ned as mesangial interposition and 
duplication of glomerular basement mem-
branes, typically associated with periph-
eral capillary wall immune deposits. Over 
the next two decades, many secondary 
forms with clear etiologic associations 
(such as related to cryoglobulinemia, dys-
proteinemia, autoimmune disease, and 
infections) were diff erentiated from the 
primary idiopathic form. But the patho-
logic classification of primary MPGN 
remained problematic because it was 
based largely on the ultrastructural 
appearance and location of deposits, 
devoid of pathogenetic context. 
 Subendothelial and mesangial deposits 
predominated in type I MPGN, where the 
membranoproliferative pattern was typi-
cally well developed. 1 Highly electron-
dense intramembranous and mesangial 
deposits were the hallmark of type II, also 
known as dense deposit disease (DDD). 2 
In type III, deposits could be subendo-
thelial and subepithelial (Burkholder 
subtype) or produce complex intramem-
branous, subendothelial, and subepithelial 
formations with fraying of the lamina 
densa (Strife and Anders subtype). 3 Even 
within the same biopsy or a given glomer-
ulus, pathologists may observe overlap-
ping features between these subtypes, 
defying easy classifi cation. While hypo-
complementemia was a well-recognized 
clinical feature of all these entities, with 
the exception of C3 nephritic factor, 
causation was largely unknown. 
 Over the next two decades, increasing 
attention was paid to the composition of 
the deposits detected by immunofl uores-
cence. Type I was typically characterized 
by deposits of immunoglobulin as well as 
complement components; type II was 
distinguished by deposits of C3 only; 
the type III Burkholder variant typically 
had deposits of immunoglobulin and 
complement; whereas the type III Strife 
and Anders variant could manifest C3 
either alone or in combination with 
immunoglobulins. As long as the patho-
genesis of these forms remained obscure, 
the classifi cation was cumbersome to use 
and perplexing to clinicians and patholo-
gists alike. 
 In the past decade, our understanding 
of the role of complement in the patho-
genesis of MPGN has illuminated the fi eld 
and led to a paradigm shift  in classifi ca-
tion ( Figure 1 ). First, the observation that 
a number of patients with intramembra-
nous dense deposits lack an MPGN pat-
tern altogether caused the designation 
MPGN II to be discarded in favor of DDD. 
Second, pathologists began emphasizing 
in their reports the presence of isolated 
deposits of C3 in examples of MPGN type 
I and type III. A major breakthrough was 
the discovery of genetic mutations or 
defi ciencies in complement-regulatory 
proteins in patients with isolated C3 
deposits. 4,5 Th ereaft er,  ‘ C3 glomerulopa-
thy ’ assumed center stage as a newly rec-
ognized subgroup encompassing DDD 
and those examples of type I and type III 
(now termed  ‘ C3 glomerulonephritis ’ ; 
C3GN) in which immunofl uorescence 
